Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling-assisted topical botulinum toxin A for enlarged facial pores (split-face RCT)
TCTR20220527006Phase 4Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A, sponsored by Siriraj Hospital. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on TCTR20220527006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220527006.